Status:
COMPLETED
Decision-Making in Bipolar Disorder
Lead Sponsor:
Emory University
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Forty subjects with bipolar disorder who are not receiving a mood-stabilizing medication for the treatment of their illness will participate in this study. The study aims to evaluate how decision-maki...
Detailed Description
Participation in this study will require three study visits over 6 weeks. Subjects will be evaluated with the Structured Diagnostic Interview for DSM-IV to confirm diagnosis. They will also be adminis...
Eligibility Criteria
Inclusion
- Male or female, age 18-65
- Primary DSM-IV TR Diagnosis of Bipolar Disorder, type I, II or NOS.
- Ability to visually read and understand English language
- Not currently taking any mood stabilizer or antipsychotic medication.
- Women of reproductive potential must be willing to take a medically approved form of birth control throughout the duration of the study.
Exclusion
- Meet criteria for substance abuse or dependence within three months of the screening visit.
- Presents with a clinically significant suicide risk, as assessed by a study physician.
- Presence of any unstable or central nervous system-related medical illness that would interfere with cognition or participation.
- Women who are currently pregnant or lactating, or plan to become pregnant during the study.
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT01463111
Start Date
May 1 2011
End Date
April 1 2016
Last Update
May 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Mood and Anxiety Disorders Program
Atlanta, Georgia, United States, 30306